ホーム › がん（全種類） › ノースカロライナ › Durham
Durham、NCにおけるがん（全種類）の臨床試験
Durhamとその周辺地域（約30マイル以内）の拠点で、がん（全種類）に関する58件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
被験者募集中第1/2相
- GSK Investigational Site, Durham
A Study of PHN-012 in Patients With Advanced Solid Tumors
被験者募集中第1相
- PHN-012-001 Site, Durham
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
被験者募集中観察研究
- The University of North Carolina Chapel Hill, Chapel Hill · 10マイル先
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
被験者募集中第2/3相
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10マイル先
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13マイル先
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
被験者募集中第3相
- Duke University Medical Center, Durham
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
被験者募集中第3相
- Duke University Medical Center - Duke Cancer Centre, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10マイル先
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
被験者募集中第3相
- Quetzal Site 27, Chapel Hill · 10マイル先
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
被験者募集中観察研究健康なボランティア歓迎
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7マイル先
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
被験者募集中第2相
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
被験者募集中第2/3相
- Duke University Medical Center, Durham
- The University of North Carolina at Chapel Hill, Chapel Hill · 10マイル先
Digital Art Therapy for Young Cancer Survivors
被験者募集中
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
被験者募集中第1相
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill · 10マイル先
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
被験者募集中第2相
- University of North Carolina at Chapel Hill, Chapel Hill · 10マイル先
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
被験者募集中第1/2相
- University of North Carolina at Chapel Hill /ID# 272454, Chapel Hill · 10マイル先
A Phase 1/1b Study of IAM1363 in HER2 Cancers
被験者募集中第1相
- Duke Cancer Institute, Durham
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
被験者募集中第3相
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · 10マイル先
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
被験者募集中第3相
- Duke Cancer Center, Durham
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
被験者募集中
- University of North Carolina at Chapel Hill, Chapel Hill · 10マイル先
Abatacept in Immune Checkpoint Inhibitor Myocarditis
被験者募集中第3相
- University of North Carolina Chapel Hill, Chapel Hill · 10マイル先
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
被験者募集中第1相
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Duke University, Durham
Behavioral Pain Intervention for Older Cancer Patients
被験者募集中
- Duke Cancer Network, Durham
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
被験者募集中第1相
- Duke Cancer Institute, Durham
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
被験者募集中健康なボランティア歓迎
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
被験者募集中第3相
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
被験者募集中第1/2相
- University of North Carolina at Chapel Hill /ID# 274667, Chapel Hill · 10マイル先
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
被験者募集中第1相
- University of North Carolina /ID# 251203, Chapel Hill · 10マイル先
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
被験者募集中第2相
- Duke University Medical Center /ID# 279457, Durham
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
被験者募集中第1相
- Duke Cancer Center, Durham
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
被験者募集中
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
被験者募集中健康なボランティア歓迎
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · 10マイル先
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
被験者募集中
- Durham VA Medical Center, Durham, NC, Durham
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
被験者募集中観察研究
- University of North Carolina, Chapel Hill · 10マイル先
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
被験者募集中第1相
- Research Site, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
被験者募集中第1相
- Duke Cancer Center /ID# 251975, Durham
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
被験者募集中第2相
- Duke Comprehensive Cancer Center, Durham
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
被験者募集中
- Durham VA Medical Center, Durham, NC, Durham
Improving Outcomes in Early Menopause After Cancer
被験者募集中
- Duke Cancer Institute, Durham
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
被験者募集中観察研究
- University of North Carolina at Chapel Hill, Chapel Hill · 10マイル先
Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors
被験者募集中健康なボランティア歓迎
- Duke Cancer Institute, Durham
UNC Metastatic Cancer Radiation Therapy Registry
被験者募集中観察研究
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10マイル先
Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors
被験者募集中観察研究
- UNC Hospitals, Chapel Hill · 10マイル先
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
被験者募集中第1/2相
- Duke University Medical Center, Duke Cancer Center, Durham
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
被験者募集中
- Durham VA Medical Center, Durham, NC, Durham
Rehabilitation Outcomes Study
被験者募集中
- The N.C. Cancer Hospital, Chapel Hill · 10マイル先
Cancer and Mild Cognitive Impairment Dyadic Intervention
被験者募集中
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
被験者募集中第2相
- University of North Carolina /ID# 233313, Chapel Hill · 10マイル先
GEMINI-NSCLC: NSCLC Biomarker Study
被験者募集中観察研究
- Duke University, Durham
- UNC, Chapel Hill · 10マイル先
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
被験者募集中
- Duke Cancer Institute, Durham
Effectiveness of Central Oncology Navigation and the Use of an ORN
被験者募集中
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)
被験者募集中
- Duke University School of Medicine, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Chapel Hill · 10マイル先
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
被験者募集中観察研究
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10マイル先
Young Adult Infusion Space Experience Satisfaction Survey
被験者募集中観察研究
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
UNC Pleural Fluid Registry
被験者募集中観察研究
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
A Study of NX-1607 in Adults With Advanced Malignancies
被験者募集中第1相
- University of North Carolina, Chapel Hill · 10マイル先
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
被験者募集中
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10マイル先
- University of North Carolina Hospitals - Hillsborough Campus, Hillsborough · 13マイル先
他の都市におけるがん（全種類）の試験
- Houston, TX121件の研究
- New York City, NY109件の研究
- Boston, MA85件の研究
- Los Angeles, CA74件の研究
- Nashville, TN65件の研究
- Philadelphia, PA59件の研究
- Washington, DC58件の研究
- Chicago, IL51件の研究
- Atlanta, GA49件の研究
- Seattle, WA49件の研究
- Arlington, VA48件の研究
- St. Louis, MO46件の研究
Durhamにおける他の研究
- 乳がん64件の研究
- 非小細胞肺癌39件の研究
- 多発性骨髄腫37件の研究
- 急性骨髄性白血病33件の研究
- 転移性癌33件の研究
- 前立腺がん32件の研究
- 肺がん32件の研究
- 大腸癌28件の研究
- 卵巣がん27件の研究
- 慢性リンパ性白血病27件の研究
- 心不全26件の研究
- 膵臓がん24件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。